Global Active Pharmaceutical Ingredients Market Report (Captive API and Merchant API) 2022 –


DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients (APIs) Market” report has been added to from offer.

The surge in corona cases around the world has played a vital role in the development of active pharmaceutical ingredient manufacturers during the forecast period.

The administration conducted molecule-by-molecule mapping of active pharmaceutical ingredients (APIs) imported from China to boost domestic construction and imports from third-party suppliers in view of supply chain disruptions due to the COVID-19 pandemic. The pandemic has added further difficulty as governments around the world have moved to boycott APIs made in China.

Regional analysis

North America is currently dominating the active pharmaceutical ingredients market and is expected to maintain its strong position for a few more years due to the increasing incidence of diseases and increasing aging population.

The European regional Active Pharmaceutical Ingredients market is expected to account for a second major market share during the forecast period.

Active Pharmaceutical Ingredients Market in Asia Pacific is considered as the most encouraging region in the Global Active Pharmaceutical Ingredients Market owing to the commoditization of rapidly emerging markets that are developing as hubs for outsourcing manufacturing of medications.

Key developments

In 2020, Pfizer (US) signed a multi-year agreement with Gilead Sciences to manufacture and supply Gilead’s antiviral drug (Remdesivir) for the treatment of COVID-19.

In 2020, Novartis (Switzerland) acquired the Japanese operations of Aspen to strengthen its position in the global market for generics and off-patent medicines. Novartis has also entered into a manufacturing and supply agreement with Aspen.

In April 2020, Boehringer Ingelheim (Germany) acquired Northern Biologics, which focuses on therapeutic antibodies targeting the tumor microenvironment. This acquisition expanded Boehringer Ingelheim’s oncology product portfolio.

Key players

Some of the major players operating in the Active Pharmaceutical Ingredients (APIs) market are

  • Aurobindo Pharma Limited

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy’s Laboratories Ltd.

  • Boehringer Ingelheim International GmbH

  • Cipla inc.

  • F. Hoffmann-La Roche SA

  • Pfizer Inc.

  • Merck & Co.

  • Teva Pharmaceutical Industries Ltd

Market Taxonomy

Business Mode

Synthesis type

Type of drug


  • Cardiology

  • Pulmonology

  • Oncology

  • Ophthalmology

  • Neurology

  • Orthopedic

  • Other Apps

For more information on this report, visit


Comments are closed.